PRENOXAD

This brand name is authorized in Australia, Estonia, France, Ireland, United Kingdom

Active ingredients

The drug PRENOXAD contains one active pharmaceutical ingredient (API):

1 Naloxone UNII F850569PQR - NALOXONE HYDROCHLORIDE

Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine. Read about Naloxone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRENOXAD Solution for injection/infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AB15	Naloxone	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11077B, 11078C
Country: EE	Ravimiamet	Identifier(s): 1626498, 1670161
Country: FR	Base de données publique des médicaments	Identifier(s): 62968616
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 223438